Virus-hijacked SOX18 pioneering activity as a viable molecular target for Kaposi sarcoma therapy Viruksen kaappaama SOX18 transkriptiotekijän pioneeritoiminta - lupaava lääkekohde Kaposin sarkoomaan
Starting year
2024
Granted funding
Päivi Ojala 
50 000 €
Funder
Cancer Foundation Finland sr.
Other information
Funding decision number
A2881
Fields of science
Cancers
Identified topics
covid, pandemic, vaccines